To further explore the mechanism of GJF intervention in the HCC process, we first screened the potential active compounds of GJF acting on HCC and clarified the molecular mechanism of GJF intervention in HCC through the PI3K/Akt signaling axis using network pharmacology. The gene discussed is AKT1; the disease is hepatocellular carcinoma.